EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study

Sammy Huygens iD, Albert Dunbar, Jochem B Buil, Corné H W Klaassen, Paul E Verweij, Karin van Dijk, Nick de Jonge, Jeroen J W M Janssen, Walter J F M van der Velden, Bart J Biemond, Aldert Bart, Anke H W Bruns und 22 weitere

Clinical Infectious Diseases · 05.07.2023 · 77 (1) · 38-45

DOI: 10.1093/cid/ciad141 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 11.03.2023. Verfasst von Sammy Huygens und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Infectious Diseases and Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Universit…. Hauptthemen laut MEDLINE: Invasive Pulmonary Aspergillosis, Aspergillosis, Invasive Fungal Infections. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gilead Sciences, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive aspergillosis (IA) by a triazole-resistant Aspergillus fumigatus is associated with high mortality. Real-time resistance detection will result in earlier initiation of appropriate therapy.

Methods

In a prospective study, we evaluated the clinical value of the AsperGenius polymerase chain reaction (PCR) assay in hematology patients from 12 centers. This PCR assay detects the most frequent cyp51A mutations in A. fumigatus conferring azole resistance. Patients were included when a computed tomography scan showed a pulmonary infiltrate and bronchoalveolar fluid (BALf) sampling was performed. The primary end point was antifungal treatment failure in patients with azole-resistant IA.

Results

Of 323 patients enrolled, complete mycological and radiological information was available for 276 (94%), and probable IA was diagnosed in 99/276 (36%). Sufficient BALf for PCR testing was available for 293/323 (91%). Aspergillus DNA was detected in 116/293 (40%) and A. fumigatus DNA in 89/293 (30%). The resistance PCR was conclusive in 58/89 (65%) and resistance detected in 8/58 (14%). Two had a mixed azole-susceptible/azole-resistant infection. In the 6 remaining patients, treatment failure was observed in 1. Galactomannan positivity was associated with mortality (P = .004) while an isolated positive Aspergillus PCR was not (P = .83).

Conclusions

Real-time PCR-based resistance testing may help to limit the clinical impact of triazole resistance. In contrast, the clinical impact of an isolated positive Aspergillus PCR on BALf seems limited. The interpretation of the EORTC/MSGERC PCR criterion for BALf may need further specification (eg, minimum cycle threshold value and/or PCR positive on >1 BALf sample).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Pulmonary AspergillosisAspergillosisInvasive Fungal InfectionsHumansProspective StudiesAzolesAspergillusAspergillus fumigatusReal-Time Polymerase Chain ReactionTriazolesAntifungal AgentsDrug Resistance, Fungal

Stichwörter der Autor:innen

Aspergillus PCRazole resistanceclinical impactinvasive aspergillosis

Substanzen

AzolesTriazolesAntifungal Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Section of Infectious Diseases and Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Department of Medical Microbiology, Radboud University Center, Nijmegen, The Netherlands.
  • Department of Medical Microbiology & Infectious Diseases, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Department of Medical Microbiology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Department of Hematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Department of Hematology, Radboud University Center, Nijmegen, The Netherlands.

ORCID-Profile: Sammy Huygens, Bart J A Rijnders

Förderung

  • Gilead Sciences, Inc

Zitieren

APA

Huygens, S., Dunbar, A., Buil, J. B., Klaassen, C. H. W., Verweij, P. E., van Dijk, K., de Jonge, N., Janssen, J. J. W. M., van der Velden, W. J. F. M., Biemond, B. J., Bart, A., Bruns, A. H. W., Haas, P. A., Demandt, A. M. P., Oudhuis, G., von dem Borne, P., van der Beek, M. T., Klein, S. K., Godschalk, P., …, & Rijnders, B. J. A. (2023). Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study. Clinical Infectious Diseases, 77(1), 38-45. https://doi.org/10.1093/cid/ciad141

Vancouver

Huygens S, Dunbar A, Buil JB, Klaassen CHW, Verweij PE, van Dijk K, et al. Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study. Clinical Infectious Diseases. 2023;77(1):38-45. doi:10.1093/cid/ciad141

BibTeX
@article{Huygens2023,
  author = {Huygens, Sammy and Dunbar, Albert and Buil, Jochem B and Klaassen, Corné H W and Verweij, Paul E and van Dijk, Karin and de Jonge, Nick and Janssen, Jeroen J W M and van der Velden, Walter J F M and Biemond, Bart J and Bart, Aldert and Bruns, Anke H W and Haas, Pieter-Jan A and Demandt, Astrid M P and Oudhuis, Guy and von dem Borne, Peter and van der Beek, Martha T and Klein, Saskia K and Godschalk, Peggy and Span, Lambert F R and Postma, Douwe F and Kampinga, Greetje A and Maertens, Johan and Lagrou, Katrien and Mercier, Toine and Moors, Ine and Boelens, Jerina and Selleslag, Dominik and Reynders, Marijke and Zandijk, Willemien and Doorduijn, Jeanette K and Cornelissen, Jan J and Schauwvlieghe, Alexander F A D and Rijnders, Bart J A},
  title = {Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {77},
  number = {1},
  pages = {38--45},
  doi = {10.1093/cid/ciad141}
}
Kostenlos starten →